Literature DB >> 6728146

Involvement of vasopressin in brain edema formation: further evidence obtained from the Brattleboro diabetes insipidus rat with experimental subarachnoid hemorrhage.

T Dóczi, F A László, P Szerdahelyi, F Joó.   

Abstract

Brain water accumulation (1.2%) with an accompanying increase in the sodium content was observed in Wistar rats as early as 1 hour after experimental subarachnoid hemorrhage (SAH). After 6 and 24 hours, the water content was 1.3 and 1.4%, respectively, higher than that of control animals. In contrast, in Brattleboro diabetes insipidus rats the content of brain water and electrolytes had not changed significantly 1 hour after the administration of blood into the subarachnoid space. Increased brain water and sodium and a normal potassium content, indicative of a vasogenic type of brain edema, were seen at 6 hours after SAH. In these animals, known to be devoid of vasopressin, the increase in brain water 24 hours after SAH was 2.6%, compared with 1.4% for Wistar rats with SAH. It is suggested that the lack of vasopressin could alter the course of brain edema formation after experimental SAH in Brattleboro diabetes insipidus rats. It is hypothesized that vasopressin, by regulating the water permeability of the brain capillaries, the choroid plexus, and the cerebrospinal fluid absorption structures, plays an important role in controlling the brain fluid and electrolyte balance during the course of SAH.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6728146     DOI: 10.1227/00006123-198404000-00008

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  18 in total

1.  Intracerebroventricular vasopressin reduces CSF absorption rate in the conscious goat.

Authors:  J R Seckl; S L Lightman
Journal:  Exp Brain Res       Date:  1991       Impact factor: 1.972

2.  Real-time monitoring of changes in brain extracellular sodium and potassium concentrations and intracranial pressure after selective vasopressin-1a receptor inhibition following focal traumatic brain injury in rats.

Authors:  Aristotelis S Filippidis; Xiuyin Liang; Weili Wang; Shanaaz Parveen; Clive M Baumgarten; Christina R Marmarou
Journal:  J Neurotrauma       Date:  2014-05-28       Impact factor: 5.269

3.  Effects of arginine vasopressin and atriopeptin on chloride uptake in cultured astroglia.

Authors:  L Katay; L Latzkovits; A Fonagy; Z Janka; A Lajtha
Journal:  Neurochem Res       Date:  1998-06       Impact factor: 3.996

4.  Cerebrospinal fluid neurohypophysial peptides in benign intracranial hypertension.

Authors:  J Seckl; S Lightman
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-12       Impact factor: 10.154

Review 5.  Volume regulation of the brain tissue--a survey.

Authors:  T Dóczi
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

6.  Effect of small molecule vasopressin V1a and V2 receptor antagonists on brain edema formation and secondary brain damage following traumatic brain injury in mice.

Authors:  Sandro M Krieg; Sebastian Sonanini; Nikolaus Plesnila; Raimund Trabold
Journal:  J Neurotrauma       Date:  2014-12-16       Impact factor: 5.269

7.  Cerebral oedema after subarachnoid haemorrhage. Pathogenetic significance of vasopressin.

Authors:  F A László; C Varga; T Dóczi
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

8.  Selective vasopressin-1a receptor antagonist prevents brain edema, reduces astrocytic cell swelling and GFAP, V1aR and AQP4 expression after focal traumatic brain injury.

Authors:  Christina R Marmarou; Xiuyin Liang; Naqeeb H Abidi; Shanaz Parveen; Keisuke Taya; Scott C Henderson; Harold F Young; Aristotelis S Filippidis; Clive M Baumgarten
Journal:  Brain Res       Date:  2014-06-13       Impact factor: 3.252

9.  Conivaptan, a Selective Arginine Vasopressin V1a and V2 Receptor Antagonist Attenuates Global Cerebral Edema Following Experimental Cardiac Arrest via Perivascular Pool of Aquaporin-4.

Authors:  Shin Nakayama; Mahmood Amiry-Moghaddam; Ole Petter Ottersen; Anish Bhardwaj
Journal:  Neurocrit Care       Date:  2016-04       Impact factor: 3.210

Review 10.  New aspects in the pathogenesis, prevention, and treatment of hyponatremic encephalopathy in children.

Authors:  Michael L Moritz; Juan Carlos Ayus
Journal:  Pediatr Nephrol       Date:  2009-11-06       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.